Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$197.5K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 56,250 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 50,974 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 95,000 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 110,000 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 82,500 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 108,622 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 25,840 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 11,284 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 3,372 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 4,909 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 25,840 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 25,840 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 12,920 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 12,920 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 10,030 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 10,030 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 41,250 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 41,250 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 1.2M | — | — | -100.0% | Open the original filing on SEC.gov |
| Jan 28 | APLS | Apellis Pharmaceuticals,… | AGRANT | 25,840 | — | — | +2.2% | Open the original filing on SEC.gov |
| Jan 22 | APLS | Apellis Pharmaceuticals,… | SSELL | 5,928 | $21.77 | $129K | -0.5% | Open the original filing on SEC.gov |
| Jan 20 | APLS | Apellis Pharmaceuticals,… | SSELL | 909 | $19.79 | $18K | <0.1% | Open the original filing on SEC.gov |
| Jan 13 | APLS | Apellis Pharmaceuticals,… | SSELL | 2,277 | $22.19 | $50.5K | -0.2% | Open the original filing on SEC.gov |
| Jun 9, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 82,500 | $19.39 | $1.6M | — | Open the original filing on SEC.gov |
| May 21, 2025 | APLS | Apellis Pharmaceuticals,… | MEXER◆ | 12,780 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | APLS | Apellis Pharmaceuticals,… | MEXER | 12,780 | $3.76 | $48.1K | +1.1% | Open the original filing on SEC.gov |